Shailesh Jejurikar, Chairman, President and CEO of Procter & Gamble Co (NYSE:PG), filed a Form 4 on September 17, 2026, disclosing the acquisition of stock options on September 15, 2026.

Key Highlights

  • Option Grant: Jejurikar acquired 22,787 stock options (Right to Buy) on September 15, 2026, at an exercise price of $146.67 per share.
  • Transaction Code: The acquisition was coded "A" (acquisition), with a price of $0 for the derivative security itself.
  • Expiration Date: The options are exercisable beginning September 14, 2029, and expire September 15, 2036.
  • Post-Transaction Derivative Holdings: Jejurikar beneficially owns 22,787 derivative securities following the reported transaction, held directly.
  • Direct Common Stock Holdings: Jejurikar directly holds 39,325.9973 shares of common stock following the reported transaction.
  • Indirect Holdings: Additional indirect holdings include 3,741.7415 shares through a retirement plan trustee, 19,757 shares through the Sankhya S Jejurikar Revocable Trust, and 35,836 shares through the Shailesh Jejurikar Trust.

Jejurikar's Option Grant and Beneficial Ownership at Procter & Gamble

According to the Form 4 filed with the SEC on September 17, 2026, Shailesh Jejurikar, identified in the filing as Chairman, President and CEO and also listed as a Director, received a grant of 22,787 stock options in Procter & Gamble Co common stock on September 15, 2026. The options carry an exercise price of $146.67 and were acquired at no cost to the reporting person, as the price of the derivative security is listed as $0. The filing notes the options become exercisable on September 14, 2029, and expire on September 15, 2036.

In Table I of the filing, covering non-derivative securities, no buy or sell transaction is reported for the September 15, 2026 date. The filing discloses Jejurikar's current beneficial ownership of common stock across multiple forms: 39,325.9973 shares held directly, 3,741.7415 shares held indirectly through a retirement plan trustee, 19,757 shares held indirectly through the Sankhya S Jejurikar Revocable Trust, and 35,836 shares held indirectly through the Shailesh Jejurikar Trust.

The Form 4 was signed by Wednesday Shipp as attorney-in-fact for Shailesh Jejurikar and dated September 17, 2026. The filing does not indicate that a Rule 10b5-1(c) plan was in effect for this transaction, as that checkbox is not marked.

What Was Disclosed

The filing reports a grant of 22,787 stock options to Procter & Gamble's Chairman, President and CEO, exercisable at $146.67 per share beginning September 14, 2029, and expiring September 15, 2036, along with the reporting person's current direct and indirect common stock holdings.